"Waitlist mortality" is high for myeloma patients with limited access to BCMA therapy.
Ahmed N, Wesson W, Mushtaq MU, Bansal R, AbdelHakim H, Bromert S, Appenfeller A, Ghazal BA, Singh A, Abhyankar S, Ganguly S, McGuirk J, Abdallah AO, Shune L.
Ahmed N, et al. Among authors: ghazal ba.
Front Oncol. 2023 Aug 3;13:1206715. doi: 10.3389/fonc.2023.1206715. eCollection 2023.
Front Oncol. 2023.
PMID: 37601685
Free PMC article.